ATE72114T1 - Oral einzunehmende kapsel mit einem nikotinhaltigen, fluessigen mittel. - Google Patents

Oral einzunehmende kapsel mit einem nikotinhaltigen, fluessigen mittel.

Info

Publication number
ATE72114T1
ATE72114T1 AT87907302T AT87907302T ATE72114T1 AT E72114 T1 ATE72114 T1 AT E72114T1 AT 87907302 T AT87907302 T AT 87907302T AT 87907302 T AT87907302 T AT 87907302T AT E72114 T1 ATE72114 T1 AT E72114T1
Authority
AT
Austria
Prior art keywords
capsule containing
liquid compound
oral capsule
nicotine liquid
nicotine
Prior art date
Application number
AT87907302T
Other languages
German (de)
English (en)
Inventor
Franz Adlkofer
Original Assignee
Forschungsgesellschaft Rauchen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forschungsgesellschaft Rauchen filed Critical Forschungsgesellschaft Rauchen
Application granted granted Critical
Publication of ATE72114T1 publication Critical patent/ATE72114T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87907302T 1986-11-18 1987-11-06 Oral einzunehmende kapsel mit einem nikotinhaltigen, fluessigen mittel. ATE72114T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19863639418 DE3639418A1 (de) 1986-11-18 1986-11-18 Nikotinhaltiges mittel
PCT/DE1987/000507 WO1988003803A1 (fr) 1986-11-18 1987-11-06 Capsule a administration orale avec un milieu fluide contenant de la nicotine
EP87907302A EP0324794B1 (de) 1986-11-18 1987-11-06 Oral einzunehmende kapsel mit einem nikotinhaltigen, flüssigen mittel

Publications (1)

Publication Number Publication Date
ATE72114T1 true ATE72114T1 (de) 1992-02-15

Family

ID=6314221

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87907302T ATE72114T1 (de) 1986-11-18 1987-11-06 Oral einzunehmende kapsel mit einem nikotinhaltigen, fluessigen mittel.

Country Status (9)

Country Link
EP (1) EP0324794B1 (OSRAM)
JP (1) JP2602043B2 (OSRAM)
CN (1) CN87107852A (OSRAM)
AT (1) ATE72114T1 (OSRAM)
AU (1) AU622101B2 (OSRAM)
BR (1) BR8707879A (OSRAM)
DE (3) DE3645036A1 (OSRAM)
DK (1) DK173353B1 (OSRAM)
WO (1) WO1988003803A1 (OSRAM)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
DE4440563A1 (de) * 1994-11-12 1996-05-15 Herzog Sen Rolf Verfahren und Mittel zum Genuß von Tabak - Nikotin unter Vermeidung schädlicher Verbrennungs - Derivate
US5604231A (en) * 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5846983A (en) * 1996-02-09 1998-12-08 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
AU2340397A (en) * 1996-03-21 1997-10-10 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
GB9614902D0 (en) * 1996-07-16 1996-09-04 Rhodes John Sustained release composition
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US6211194B1 (en) * 1998-04-30 2001-04-03 Duke University Solution containing nicotine
US6268386B1 (en) * 1998-06-25 2001-07-31 Marshall Anlauf Thompson Nicotine beverage
GB2338896B (en) 1998-07-02 2003-05-21 Reckitt & Colmann Prod Ltd Chewable Capsules
US8188043B2 (en) 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
CA2380072C (en) 1999-07-28 2007-07-10 John Cooke Nicotine in therapeutic angiogenesis and vasculogenesis
AT409219B (de) * 1999-08-13 2002-06-25 Red Bull Gmbh Verwendung von nikotin zum herstellen von arzneimitteln
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
ATE359075T1 (de) 2002-12-20 2007-05-15 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
WO2005007068A1 (en) * 2003-07-22 2005-01-27 The Kiwigel Company Limited Nicotine packaging system
US20070191815A1 (en) 2004-09-13 2007-08-16 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
NO20042835D0 (no) * 2004-07-05 2004-07-05 Nils-Erik Skeide Innkapslet tobakksroyk
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
EP2322168A1 (en) * 2007-04-02 2011-05-18 Parkinson's Institute Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
CN101249130B (zh) * 2008-04-11 2011-06-15 桂林商源植物制品有限公司 一种戒烟并缓解戒烟综合症的药用或保健组合物
CA2841785A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
WO2016188932A2 (en) * 2015-05-22 2016-12-01 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Combination compositions and their use in methods for treating obesity and obesity-related disorders
CN105341990A (zh) * 2015-12-16 2016-02-24 浙江中烟工业有限责任公司 一种提升电子烟生理满足感的电子烟烟液
JP2020503950A (ja) 2017-01-06 2020-02-06 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 経皮薬剤送達の装置及び方法
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム
CA3119992A1 (en) 2018-11-16 2020-05-22 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU432703A3 (OSRAM) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
US3870794A (en) * 1974-02-20 1975-03-11 Foundation For Behavioral Rese Treatment of certain emotional disorders with nicotine compounds
GB1528391A (en) * 1976-01-05 1978-10-11 Gildemeister V Aerosol compositions
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
BE899037A (fr) * 1984-02-29 1984-06-18 Trenker Ady Composition a sucer permettant de cesser de fumer
DE3438284A1 (de) * 1984-10-16 1985-03-07 Hans-Harald von 2400 Lübeck Tilly Nikotinhaltiges depotpflaster
EP0186502A3 (en) * 1984-12-25 1986-12-10 Jano Tyroler Flavor capsule and method of preparing same
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment

Also Published As

Publication number Publication date
AU622101B2 (en) 1992-04-02
EP0324794B1 (de) 1992-01-29
CN87107852A (zh) 1988-06-22
DE3639418A1 (de) 1988-06-09
JPH02501304A (ja) 1990-05-10
EP0324794A1 (de) 1989-07-26
DK173353B1 (da) 2000-08-07
DE3645036A1 (de) 1989-01-05
DK385888A (da) 1988-07-08
WO1988003803A1 (fr) 1988-06-02
DK385888D0 (da) 1988-07-08
BR8707879A (pt) 1989-10-03
DE3639418C2 (OSRAM) 1989-08-03
AU8171287A (en) 1988-06-16
JP2602043B2 (ja) 1997-04-23
DE3776574D1 (de) 1992-03-12

Similar Documents

Publication Publication Date Title
ATE72114T1 (de) Oral einzunehmende kapsel mit einem nikotinhaltigen, fluessigen mittel.
Ernster Mixed messages for women: a social history of cigarette smoking and advertising.
GB1315626A (en) Substituted p-menthanes and compositions containing them
ES2009915A6 (es) Un procedimiento para preparar una composicion que comprende cefuroximo-axetil en forma de particulas.
ES8308211A1 (es) Un metodo de preparar un polvo seco que comprende un farmaco encapsulado con etilcelulosa, poli (acetato de vinilo) u otros polimeros.
EP0146334A3 (en) Chewing tobacco product
DE69519300D1 (de) Stabiles arzneimittel enthaltend oxaliplatin
BG42000A3 (en) Method for preparing suspension of microcapsulated bacampicilline salt of acid incorporation
ES8501613A1 (es) Un procedimiento para fabricar una goma de mascar aromatizada con cola
IT1147157B (it) Dispositivo regolatore per regolare il tabacco trinciato ricircolato al distributore di una confezionatrice di sigarette
ITMI911791A0 (it) Composizioni farmaceutiche per la terapia dell'astinenza, del "craving" della dipendenza da sostanze stupefacenti da sostanze psicoattive, da nicotina e dei disturbi alimentari
FR2429783A1 (fr) Nouveaux derives de vitamines d et leur application en therapeutique
ES8302454A1 (es) "un metodo para preparar una composicion solida y estable a base de un farmaco facilmente oxidable al aire".
Perel et al. Studies on plasma level/effect relationships in imipramine therapy.
GB1413177A (en) Process for the manufacture of regenerated tobacco
GB1486687A (en) Iron-resin adsorbate
FR2603166B1 (fr) Lait chocolate
ES398108A1 (es) Un metodo para la preparacion de una composicion de aneste-sico local.
JPS52108014A (en) Artificial saliva
JPS6413019A (en) Aldose reductase inhibitor
GB1336610A (en) Antismoking chewing gum preparation
KR890015746A (ko) 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법
DE3673884D1 (de) Festes arzneimittel zur oralen verabreichung.
GB1528786A (en) Smoking composition
NL191611C (nl) Van benzonorborneen afgeleide verbinding met differinische werking en zouten daarvan, werkwijze ter bereiding daarvan alsmede geneesmiddelpreparaat en kosmetisch preparaat die deze verbinding bevatten.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee